Table 1 The effect of ESA on some of the neurophysiological findings and Hb levels in comparison to those of patients who did not receive ESA
Nerve (n = 10) | 0A | 3A | p | Nerve (n = 8) | 0B | 3B | p |
|---|---|---|---|---|---|---|---|
Median (n = 10) | Median (n = 8) | ||||||
MNCV | 49.51 ± 5.77 | 47.3 ± 5.6 | 0.094 | MNCV | 47.89 ± 7.53 | 47.05 ± 6.87 | 0.300 |
CMAP | 5.97 ± 2.34 | 5.36 ± 2.15 | 0.469 | CMAP | 7.34 ± 4.72 | 6.28 ± 3.64 | 0.392 |
Ulnar (n = 10) | Ulnar (n = 8) | ||||||
MNCV | 44.87 ± 6.7 | 50.02 ± 5.55 | 0.016 | MNCV | 49.04 ± 4.95 | 48.01 ± 6.43 | 0.431 |
CMAP | 5.97 ± 2.08 | 7.38 ± 2.08 | 0.067 | CMAP | 5.54 ± 1.86 | 5.8 ± 1.54 | 0.705 |
Peroneal (n = 8)* | Peroneal (n = 7)* | ||||||
MNCV | 40.91 ± 5.57 | 38.95 ± 4.96 | 0.188 | MNCV | 40.26 ± 7.89 | 39.16 ± 8.61 | 0.358 |
CMAP | 2.38 ± 1.65 | 3.64 ± 2.8 | 0.134 | CMAP | 4.09 ± 2.49 | 3.28 ± 2.63 | 0.203 |
Tibial (n = 7)* | Tibial (n = 7)* | ||||||
MNCV | 41.31 ± 2.31 | 43.37 ± 4.64 | 0.126 | MNCV | 41.14 ± 8.92 | 37.96 ± 6.67 | 0.202 |
CMAP | 3.97 ± 1.49 | 7.01 ± 5.28 | 0.262 | CMAP | 3.87 ± 1.49 | 3.70 ± 1.97 | 0.733 |
Median (n = 7)* | Median (n = 7)* | ||||||
SNCV | 46.51 ± 5.8 | 48.57 ± 5.5 | 0.263 | SNCV | 47.27 ± 9.23 | 45.97 ± 7.8 | 0.440 |
Ulnar (n = 7)* | Ulnar (n = 6)* | ||||||
SNCV | 45.3 ± 6.44 | 46.5 ± 12.6 | 0.740 | SNCV | 46.88 ± 12.0 | 46.52 ± 12.4 | 0.935 |
Radial (n = 7)* | Radial (n = 6)* | ||||||
SNCV | 48.2 ± 7.53 | 54.06 ± 4.6 | 0.009 | SNCV | 49.62 ± 10.36 | 0.527 | |
Sural (n = 5)* | Sural (n = 4)* | ||||||
SNCV | 37.92 ± 6.7 | 24.56 ± 22.44 | 0.352 | SNCV | 45.73 ± 5.44 | 46.53 ± 3.69 | 0.763 |
Hb (g/dl) | 7.92 ± 1.08 | 9.36 ± 0.8 | 0.000 | 8.33 ± 1.74 | 8.91 ± 1.09 | 0.139 |